The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Ethics Forum: Righting the Wrong Diagnosis

Ethics Forum: Righting the Wrong Diagnosis

May 18, 2018 • By Joseph L. Green, DO

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Yury Zap / shutterstock.com

Yury Zap / shutterstock.com

A 54-year-old woman is establishing care in your clinic after retirement of her previous rheumatologist. Your review of her records suggests that she was diagnosed with systemic lupus erythematosus seven years ago on the basis of symptoms of body pain and fatigue, and serologic evidence of positive ANA 1:40 (speckled) and borderline anti-SSB antibody. She is currently on hydroxychloroquine 200 mg BID and prednisone 5 mg daily. She has hypertension, well controlled with amlodipine 5 mg daily, but has otherwise been healthy. Her body pain and fatigue resolved after she quit her stressful job.

You Might Also Like
  • Ethics Forum: The Ethics of Accepting Gifts
  • Ethics Forum
  • Ethics Forum: Patient Test Requests Pose Challenges for Rheumatologists
Explore This Issue
May 2018

During the clinic encounter, you notice that she is wearing a Lupus Foundation of America T-shirt and learn that she is a leader of a lupus support group in her community. You were planning on discussing the possibility of her not having lupus but now are hesitant to bring up the conversation.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Discussion

Establishing a rheumatic diagnosis can sometimes be challenging, especially in patients with vague symptomatology and a paucity of clinical and serologic findings. Considering the potential toxicity profiles of anti-rheumatic agents, a questionable diagnosis can be detrimental to a patient’s health.

A Lupus Foundation of America study involving 3,022 individuals found that 41% of patients with musculoskeletal symptoms were initially misdiagnosed as not having lupus, even though 76.5% of those patients had discussed their symptoms with a rheumatologist. In addition, 40% of the patients were given a diagnosis of lupus more than one year after onset of symptoms.1 Further, a study published in 2017 focusing on rheumatoid arthritis patients showed the median time from symptom onset to treatment was approximately one year, with a range of four to 24 months.2

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

These studies highlight the fact that making an accurate diagnosis is difficult even with rheumatologic conditions common to our profession and even in the hands of an experienced rheumatologist. In light of the aforementioned evidence, we, as clinicians, will be confronted by discussions with our patients about possible misdiagnoses and the potential for discontinuing associated pharmacologic treatment that they may have been receiving for years.

The imperative for accurate diagnosis and treatment is elaborated by the ACR Code of Ethics, which states: “Members shall be dedicated to providing competent medical care with compassion and respect for human dignity and rights, and shall regard responsibility to the patient as paramount.”3

Our duty is to meticulously evaluate the available data before accepting or rejecting an already established diagnosis.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 | Single Page

Filed Under: Ethics Tagged With: Diagnosis, EthicsIssue: May 2018

You Might Also Like:
  • Ethics Forum: The Ethics of Accepting Gifts
  • Ethics Forum
  • Ethics Forum: Patient Test Requests Pose Challenges for Rheumatologists
  • Ethics Forum: Personal Ethics Questions Surrounding RheumPAC Donations

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)